drugset / Trial / NCT00415805

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

NCT00415805

Phase 3 Completed 39 enrolled Bracco Diagnostics, Inc
RandomizedCrossoverDouble-blindDiagnostic

Summary

This is an explorative small pilot study comparing two MRA contrast agents, one of which has been on the market for a few years and the other fairly new to the market. Since the study is explorative and designed to provide preliminary information for consideration for a future larger study, sample size is not based on statistical assumptions.

Timeline

Start
2006-12
Primary completion
2008-12
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobenate dimeglumine Diagnostic / imaging agent
Comparator Vasovist Diagnostic / imaging agent

Indications